Latest news is listed below. Click on the links to read the full articles.

  • 20 Jun 2012 Science Council focuses on actions for sustainability of research centres

    The Advisory Council on Science, Technology and Innovation (ACSTI) today made a series of recommendations on how best to support research centres in Ireland with a view to optimising future potential social and economic returns from State investments in research, development and innovation (RD&I).

  • 05 Jul 2011 ACSTI Welcomes New Members

    The Forfás Board, is delighted to announce the appointment of Dr David Lloyd, Dean of Research, Molecular Design Group founder and Hitachi Lecturer in Advanced Computing, School of Biochemistry and Immunology, Trinity College Dublin; Kevin O'Leary, Chief Executive Officer, Qumas and Julie O'Neill, Vice President, Operations and General Manager, Gilead Sciences Ltd as members of the Advisory Council on Science, Technology and Innovation.

  • 17 Jan 2011 Ireland must continue to support research and innovation for stability and growth

    The Advisory Council for Science, Technology and Innovation (ACSTI) today published a statement highlighting the main areas which need to be addressed to ensure Ireland continues to support research and innovation as key priorities for economic and employment stability and growth. The statement, “Staying the Course”, gives the Council’s views on what can be done now to support the research community and the R&D-based enterprise sector.

  • 15 Dec 2009 Employing PhD Graduates Benefits Irish Enterprise

    A new report launched today by the Advisory Council for Science, Technology and Innovation (ACSTI) has found that Irish R&D firms employing PhD researchers have rates of patenting 2.5 times greater than similarly active firms which do not employ PhD researchers and have vastly higher collaboration rates with both Higher Education Institutes and other firms. While only 29% of R&D active firms employed PhD researchers in 2007, these companies accounted for 70% of business expenditure on R&D.